Cargando…

The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines

Introduction: Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirshekari, Mehrzad, Shirzad, Nooshin, Hemmatabadi, Mahboobeh, Namazi, Soha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278195/
https://www.ncbi.nlm.nih.gov/pubmed/37342668
http://dx.doi.org/10.34172/jcvtr.2023.31585
_version_ 1785060432588832768
author Mirshekari, Mehrzad
Shirzad, Nooshin
Hemmatabadi, Mahboobeh
Namazi, Soha
author_facet Mirshekari, Mehrzad
Shirzad, Nooshin
Hemmatabadi, Mahboobeh
Namazi, Soha
author_sort Mirshekari, Mehrzad
collection PubMed
description Introduction: Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. Methods: A structured questionnaire was prepared. Questions (n=24) included the demographics (n=7), dyslipidemia references (n=3), dyslipidemia general knowledge of respondents (n=10), and questions (n=4) designed based on the difference among the latest version of guidelines participants stated they use in their practice. After validity conformation, the questionnaire was distributed to 120 clinical pharmacists, electronically from May to August 2021. Results: Response rate was 77.5% (n=93). The majority of participants (80.6%, n=75) claimed to have used the 2018 ACC/AHA guideline. The Median (interquartile range [IQR]) score of the general knowledge questions was 5.0 (2.0) out of 10. The Median (IQR) score of questions designed based on the difference among guidelines was calculated 3(1) out of 4. There was no significant (P=0.25) difference in score among participants according to their guideline selection. Moreover, the gender and length of experience as a clinical pharmacist had no significant (P>0.05) effect on the score of participants. Conclusion: In this study, Iranian clinical pharmacists answered half of the dyslipidemia general knowledge questions correctly. Also, Participants were up-to-date on 75% of the questions designed based on the latest version of the guideline they had been using in their practice.
format Online
Article
Text
id pubmed-10278195
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Tabriz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-102781952023-06-20 The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines Mirshekari, Mehrzad Shirzad, Nooshin Hemmatabadi, Mahboobeh Namazi, Soha J Cardiovasc Thorac Res Original Article Introduction: Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. Methods: A structured questionnaire was prepared. Questions (n=24) included the demographics (n=7), dyslipidemia references (n=3), dyslipidemia general knowledge of respondents (n=10), and questions (n=4) designed based on the difference among the latest version of guidelines participants stated they use in their practice. After validity conformation, the questionnaire was distributed to 120 clinical pharmacists, electronically from May to August 2021. Results: Response rate was 77.5% (n=93). The majority of participants (80.6%, n=75) claimed to have used the 2018 ACC/AHA guideline. The Median (interquartile range [IQR]) score of the general knowledge questions was 5.0 (2.0) out of 10. The Median (IQR) score of questions designed based on the difference among guidelines was calculated 3(1) out of 4. There was no significant (P=0.25) difference in score among participants according to their guideline selection. Moreover, the gender and length of experience as a clinical pharmacist had no significant (P>0.05) effect on the score of participants. Conclusion: In this study, Iranian clinical pharmacists answered half of the dyslipidemia general knowledge questions correctly. Also, Participants were up-to-date on 75% of the questions designed based on the latest version of the guideline they had been using in their practice. Tabriz University of Medical Sciences 2023 2023-03-16 /pmc/articles/PMC10278195/ /pubmed/37342668 http://dx.doi.org/10.34172/jcvtr.2023.31585 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mirshekari, Mehrzad
Shirzad, Nooshin
Hemmatabadi, Mahboobeh
Namazi, Soha
The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
title The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
title_full The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
title_fullStr The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
title_full_unstemmed The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
title_short The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
title_sort approach of iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278195/
https://www.ncbi.nlm.nih.gov/pubmed/37342668
http://dx.doi.org/10.34172/jcvtr.2023.31585
work_keys_str_mv AT mirshekarimehrzad theapproachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines
AT shirzadnooshin theapproachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines
AT hemmatabadimahboobeh theapproachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines
AT namazisoha theapproachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines
AT mirshekarimehrzad approachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines
AT shirzadnooshin approachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines
AT hemmatabadimahboobeh approachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines
AT namazisoha approachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines